Rebecca Fitzgerald

Rebecca Fitzgerald OBE FRS FMedSci FRCP EMBO is  Professor of Cancer Prevention and Founding Director of the Early Detection Institute at the University of Cambridge and practices medicine as Hon. Consultant in Gastroenterology and Cancer Medicine at Addenbrooke's Hospital.

Rebecca developed a first in class early detection technology for oesophageal cancer. She founded Cyted Health in 2019 and has licensed technology to Covidien (now Medtronic). Rebecca is passionate about supporting health-care and biotech start-ups from the Cambridge biomedical campus.